The Prime Therapeutics Report is your trusted source for the latest in managed care strategies, specialty drug trends and payer-focused insights. The Summer 2025 issue features a cover story on HIV treatment, including updates on pre-exposure prophylaxis, post-exposure prophylaxis and therapies in the pipeline. The report also highlights developments in: 

• Duchenne Muscular Dystrophy (DMD): 
  • Focus on new gene therapies 
  • Considerations for payers and reimbursement 
• Biosimilar Market: 
  • Latest updates and trends 
• Ophthalmology: 
  • Insights into anti-VEGF agents used in eye treatments 
• Cardiology: 
  • Advances in managing transthyretin amyloid cardiomyopathy 

Explore the report